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Abstract 
The growth hormone (GH) and insulin-like factor 1 (IGF-1) growth axis is integral to 
growth, metabolism and tissue repair. This pathway involves binding of GH to the GH 
receptor and activation of the transcription factor, Stat5b, leading to nuclear 
transclocation, interaction with DNA binding sites in chromatin and stimulation of IGF-1 
transcription. Stat5b binding sites have been determined experimentally by previous 
research but are all found far from the IGF-1 promoters and the mechanism by which 
Stat5b binding initiates IGF-1 gene transcription is currently unknown. Since no system 
for studying this process currently exists, the goal of this project is to create a cell-based 
transcriptional test system by placing the rat IGF-1 locus in the form of a linearized 
bacterial artificial chromosome (BAC) into mammalian cell line. The transgene then will 
be studied for GH regulation, Stat5b binding to specific DNA sequences, and the long 
distance interactions between Stat5b binding sites and the IGF-1 gene promoters that are  
for activating IGF-1 gene transcription. If successful, this project will help to answer 
fundamental questions about the GH IGF-1 growth axis, more specifically the role of 
Stat5b. 
 
Introduction 
Physiology of Growth Hormone. Growth hormone (GH) is produced and secreted from 
the anterior pituitary gland.1 GH promotes growth throughout childhood and plays a role 
in metabolism and tissue repair throughout life.2 Having an over-abundance of circulating 
GH can cause disorders such as gigantism in children and acromegaly in adults.3,4 In 
contrast, GH deficiency in children causes severe growth defects, which can be treated 
with exogenous GH 5. The GH-mediated growth axis is relatively well conserved among 
vertebrates and highly conserved among mammals.6  
Growth Hormone Receptor and Signaling. GH acts by binding and activating a 
transmembrane receptor. The growth hormone receptor (GHR) is a member of the class 1 
cytokine family and it has an extracellular N-terminal domain, a single transmembrane α-
helix, and a C-terminal intracellular segment.7 The intracellular part of the GHR is 
associated with the protein tyrosine kinase, Janus kinase 2 (JAK2). Upon binding of GH 
to the extracellular part of the GHR, the receptor undergoes a conformational change, 
which leads to activation of JAK2, and phosphorylation of multiple tyrosine residues 
within the intracellular part of the GHR by JAK2.8 These phospho-tyrosine residues 
function as docking sites for signaling proteins that mediate the biological effects of the 
activated GHR (Figure 1). As seen with defects in GH, mutations in the GHR also lead to 
growth deficiency and short stature, but these cannot be treated successfully with GH.9  
Stats Regulate Growth Hormone –Mediated Gene Transcription. Stats (Signal 
Transducers and Activators of Transcription) comprise a conserved family of seven 
transcription factors in mammals (Stats 1, 2, 3, 4, 5a, 5b, and 6) that act downstream of 
 
Figure 1. Growth Hormone Signaling Pathway. GH binds to the GHR activating the GHR. JAK2, covalently 
bound to the GHR becomes activated upon GHR activation and phosphorylates the Tyr residues in the 
intracellular part of the GHR. Latent proteins in the cytoplasm, including Stat5b, move to the receptors to 
become activated by phosphorylation. Once activated, Stat5b forms a dimer with other activated Stat5b 
proteins and enters the nucleus where it binds to the DNA to initiate transcription. 
Figure 2. Stat Structure. Stats have a similar structure. The unique structure of the protein arises from the 
DNA-Binding Domain, the region which allows it to bind DNA (Blue), the SH2 domain, the region which 
allows it to bind to other activated Stats (Red, Left), and the transactivation domain (TAD) which allows it 
to interact with proteins involved in transcription (Red, Right). 
activated cytokine receptors, including the GHR. Stats are latent in the cytoplasm until 
they are recruited to the binding sites that contain phosphorylated tyrosine residues of 
activated cytokine receptors, where they undergo phosphorylation on a single critical 
tyrosine residue (Figure 1).10 This leads to Stat activation through separate steps 
including dissociation from the receptor, dimerization, and translocation into the nucleus. 
In the nucleus, activated Stats bind to specific DNA sequences at regulatory sites on 
target genes, setting into motion events that stimulate gene transcription. Stats all have a 
general modular structure, which includes a coiled-coil region, a DNA binding domain, a 
SH2 domain, and a transactivation domain (TAD) (
Figure 2).11 The DNA binding domain is the region of the protein which allows the Stat to 
bind to the DNA. The region of the protein which allows the Stats to form dimers is the 
SH2 domain. The TAD is the part of the protein which recognizes specific DNA 
sequences and allows it to interact with other proteins that initiate transcription. Among 
the several Stats that are activated by the GHR and JAK2, Stat5b appears to be the 
critical growth regulating transcription factor12 as inactivating mutations also have been 
found in individuals with growth deficiency and short stature.13  
Growth Hormone Signaling and IGF-I. Insulin-like growth factor-I (IGF-I) is a 70-amino 
acid circulating peptide that also is critical for growth during childhood, and plays an 
important role in tissue maintenance and repair in the adult.14 The production of IGF-1 is 
under control of GH, and rare defects in IGF-I also cause severe growth failure in 
children.15 GH promotes synthesis of IGF-I by stimulating IGF-I gene expression through 
induction of IGF-I gene transcription,16 a process also mediated by Stat5b. The focus of 
this research project will be on how GH via Stat5b activates IGF-I gene transcription. 
 
Figure 3. IGF-1 gene structure. The rat IGF-1 gene locus is shown with its two promoters and its 6 exons. 
The human gene is organized similarly. The postulated Stat5b binding sites are the red dots.  
 
IGF-I gene organization and regulation. In humans, the IGF-1 gene is located on 
chromosome 12 and spans more than 80 kb of genomic DNA. The gene consists of 6 
exons and 5 introns.17 IGF-I genes in other mammals are organized similarly.7 IGF-I gene 
(Figure 3) transcription is controlled by two adjacent promoters18, each with its own 
leader exon. The transcribed IGF-I RNA undergoes alternative splicing and differential 
polyadenylation in the nucleus to yield multiple IGF-I mRNA species. After transport 
into the cytoplasm the IGF-I mRNAs are translated into two distinct IGF-I precursor 
proteins, which are processed into identical 70-amino acid mature IGF-I protein. 19 
Main questions and project overview. The mechanism by which Stat5b regulates the 
transcription of IGF-1 is not clear. It is known Stat5b binds to specific DNA sequences 
within the IGF-1 locus (Figure 3) and that Stat5b is required for IGF-1 gene transcription, 
but the mechanisms connecting Stat5b binding to sites20,21 far from the IGF-1 promoters 
which initiate promoter activity are unknown. Also unknown is exactly how the DNA 
must be conformed in order to bring the Stat5b site close enough to the promoter to 
initiate transcription. The goal of this project will be to help answer these questions by 
creating a model cell-based system to study activation of the IGF-1 gene by Stat5b. This 
will involve placing the rat IGF-1 locus into mammalian cells in culture and studying the 
transgene for regulation by GH, for binding of Stat5b to specific recognition sites, and for 
potential interaction between each Stat5b site and the IGF-1 gene promoters. 
Subsequently, the Stat5b binding sites will be removed in order to determine which are 
most important in mediating GH stimulated transcriptional activation. We could then 
begin to answer questions about the mechanism of GH regulation of IGF-1 transcription 
and the role Stat5b plays.  
Materials and Methods 
BAC Preparation. A bacterial artificial chromosome (BAC) containing a fragment of rat 
genomic DNA spanning the IGF-1 gene in the plasmid pTARBAC2.1 was obtained from 
Children’s Hospital Oakland Research Institute (CH230-113M6). For digestion analysis 
and PCR, the DNA was isolated using a modified alkaline lysis protocol (from Colin 
Powers, Fruh Lab, OHSU, and buffers from Qiagen, Valencia, CA): A 10 mL culture was 
grown overnight in a bacterial incubator-shaker at 37°C and 275 rpm. The bacterial pellet 
was precipitated after centrifugation at 3000 rpm at 4°C for 20 min. The pellet was 
suspended in Qiagen buffer P1 (250 µl; 50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 100 
µg/mL RNase A). Qiagen buffers P2 (300 µl; 200 mM NaOH, 1% SDS) and P3 (300 µl; 
3.0 M KCH2COOH, pH 5.5) were added followed by addition of 500 µl of a phenol-
choloroform-isoamyl alcohol solution (ratio of 25:24:1). Samples were rotated in a 
Labquake (Thermoscientifc, Ashville, NC) at 30 rpm for 10 min at 4°C and separated by 
centrifugation at 14,000 rpm for 15 min. The aqueous layer was transferred to new 
centrifuge tube, followed by addition of 3M Na Acetate (100 µl) and 95% ethanol (1000 
µl), and incubation at -80°C overnight. Tubes were removed from -80°C and centrifuged 
at 14,000 rpm for 20 min. The pellet was gently suspended in 500 µl of 70% ethanol and 
centrifuged at 14,000 rpm for 10 min twice. The BAC DNA was dissolved in 50 µl 
double deionized water (ddH2O). As a quality control, 2 µg of each BAC DNA sample 
was digested with EcoRI, or BamHI.  The digestion patterns are used for references of 
BAC presence in miniprep solutions. For obtaining BAC DNA for Cos7 transfection, the 
BAC was isolated using the Nucleobond BAC 100 DNA isolation kit (Machery-Nagel, 
Bethlehem, PA). This DNA (1-5 µg) was then transformed by electroporation (2.5kV, 25 
µF and 200Ω) using the BIORAD Gene Pulser II (BIORAD, Hercules, CA) into a strain 
of recombination competent E.coli (SW102), plated on chloramphenicol plates. DNA 
from colonies was isolated by the modified alkaline lysis protocol, and analyzed by 
digestion and PCR. Glycerol stocks were made and stored at -80°C for future use. 
Neomycin/Kanamycin cassette design. The Neomycin/Kanamycin (Neo/Kan) cassette 
was designed by cloning 500 bp homology arms into neomycin and ampicillin containing 
plasmid PL452. The two 500 bp homology arms, termed A and B, were synthesized by 
PCR (see Appendix A) using primers specific to two 500 bp regions on the BAC located 
3’ of the IGF-1 gene. The region of Arm A was located at relative position +84171 to 
+86669 and B was located at +84672 to +85220 region, relative to the +1 transcription 
start site of the IGF-1 gene. Arm A was added to PL452 at EcoRI and NheI restriction 
enzyme sites, and B was added at BamHI and NotI sites. For each step the digested DNA 
was combined (3:1 molar ratio insert to vector) with 1X T4 ligase buffer and T4 DNA 
ligase (Fermentas Glen Burnie, MD) for 5 min at 20°C. Competent E. coli were 
transformed with ligations and kept on ice for 30 min. The E.coli was “heat- shocked” at 
42°C for 30 sec, antibiotic free media was added and E. coli were incubated for 1 hr at 
37°C with 250 rpm shaking. After incubation, the E. coli were plated on agar plates 
containing LB media + 25 µg/ml ampicillin or kanamycin, and incubated overnight at 
37°C. Selected colonies were screened using the synthetic primers specified for Arm A. 
The plasmid DNA was isolated from positive clones after overnight culture in 10 mL of 
LB containing media + 25 µg/ml ampicillin at 275 rpm and 37°C. The plasmid DNA was 
digested with EcoRI and NheI or BamHI and NotI  to confirm Arm A or Arm B, 
respectively. Final confirmation of Arms A and B in PL452 was established by DNA 
sequencing using vector specific primers. The PL452 plasmid containing the homology 
arms A and B was used as a template for long-range PCR using the modified forward 
primer of Arm A, adjusted 50 bp towards Neo, and the reverse modified primer of Arm 
B, also moved 50 bp towards Neo, to isolate the cassette followed by a DpnI treatment 
and cleaning with the Qiagen PCR Cleaning Kit. The PCR product was electroporated 
(2.5kV, 25 µF and 200Ω; see Appendix B) into E.coli as described above. Clones were 
screened by PCR for the presence of the cassette in the BAC.  
Neomycin containing BAC transformation into Cos7 cells. Passage 7 Cos7 cells were 
grown in antibiotic free DMEM (Life Technologies, Grand Island, NY) until 65-70% 
confluency. Cos7 cells (1∙107 cells) were electroporated (300V, 950 µF, 200 Ω; See 
appendix B) with 1000 ng of linearized DNA of Neo containing BAC. Cells were plated 
and grown in antibiotic free DMEM for 48 hr at 37°C. DMEM was replaced with DMEM 
+ G418 (200 µg/mL) and media was changed every 48 hrs for 2-3 weeks. Cells surviving 
G418 treatment will be harvested and screened for the integration of the Rat IGF-1 locus.  
 
Figure 4. Schematic of Recombination. The homology arms are cloned into the PL452 plasmid. The 
cassette containing the homology arms is separated from the plasmid using the modified primers in (B) 
with long range PCR and transformed by electroporation into the E.coli containing BAC. 
   
Results/Discussion 
Project Overview. There is no system currently in place to study the mechanism of the 
GH regulation of IGF-1 via Stat5b. The goal of this project ( Figure 5) is to create a 
model system in which this mechanism can be closely studied. This will involve 
transfecting the about 250 kb of the IGF-1 gene locus into a cell line and stabilizing it by 
making it essential to the cell. To do this, antibiotic resistance to Geneticin (G418) will 
be added to 
 
Figure 5. Project overview. These are the main objectives in the project. 
 
the gene prior to transfection. The selection pressure will be applied throughout the 
experiment to ensure only those cells containing the integrated transgene are able to 
survive the treatment. Once this model system is created, it will allow for a system in 
which experiments to be conducted to study the Stat5b mediated GH regulation of IGF-1 
transcription.  
Addition of selectable marker. Before the BAC can be placed into cell culture, it must be 
modified so cells which integrated the BAC into their genomic DNA can be distinguished 
from the cells which did not. The most efficient way to do this is by addition of a 
selectable marker which is a gene that allows for resistance against antibiotics, in this 
case Neomycin, which is complete with its own prokaryotic and eukaryotic promoters. 
These promoters allow the antibiotic selection to be used in both E. coli and Cos7 cell 
culture. Inserting this gene into the BAC was achieved by recombination based gene 
engineering, or recombineering (Figure 6). Recombineering is a method using modified 
E. coli strains which contain genes, exo, bet and gam from λ-phage technology. These 
  
Figure 6. Recombineering. The process of recombineering involves selecting the location of the gene 
insertion, amplifying the region by PCR and inserting them around the gene of interest. By adding the 
isolated cassette to the BAC in the special strain of E. coli which contains the genes required for foreign 
DNA insertion, the new gene can be inserted. 
genes are under the control of a temperature sensitive promoter which when activated, 
produces proteins that allow foreign DNA to be inserted by homology into another DNA 
fragment. Homology arms, small DNA fragments made from the BAC from the desired 
location for the insert of the gene, are inserted into either side of the gene creating a 
cassette (Figure 7). The cassette is then recombined into the BAC providing antibiotic
 
Figure 7. Neomycin cassette. The neomycin cassette is made up of its two promoters, one that is 
functional in prokaryotic organisms (pGK) and the other functional in eukaryotic organisms (pGH). 
Surrounding the gene are the A and B homology arms (Blue). 
 resistance to Geneticin  (G418) when in cell culture and Neomycin with in E. coli. When 
this BAC is modified in E. coli, the clones can be grown on neomycin selection plates 
and only the ones containing this marker will survive the treatment. The process is 
similar in cell culture because only the cells which integrate the BAC into their genome 
will survive the G418 treatment. The successful integration of the gene be confirmed 
after the selection step by screening for the gene by PCR. The PCR screen in Figure 8B 
shows the successful integration of the neomycin gene into the BAC using primers 
oriented as in Figure 8A. 
 Figure 8. PCR Screen for Presence of Neo Cassette in the BAC. (A) The schematic for the positions of 
the screening primers for Arms A and B. (B) PCR screen for the presence of Arm A (Labeled 1), Arm B 
(Labeled 2), BAC (positioned at -10kb from exon 1 on the IgfI gene) (Labeled 3) and Neo cassette 
(positioned within the Neo gene) (Labeled 4). M is the 1kb ladder. 
 
BAC Transformation into the Cos7 cell line. After successfully integrating the resistance 
marker to the DNA, the BAC DNA was linearized and transfected into Cos7 cells. The 
cells will then be grown in G418 for 2-3 weeks, harvested and screened by PCR for the 
integration of the IGF-1 gene. If the integration of the IGF-1 gene can be confirmed, we 
can then begin to take the next steps to confirm the system works by stimulating it with 
GH. If the system works, IGF-1 will be produced and we will be able to start designing 
experiments to study the mechanism of GH regulated IGF-1 transcription. From this 
system we can study the amount of IGF-1 protein produced compared to normal levels of 
IGF-1 protein production when stimulated by GH. The structure and the amount of 
mRNA can also be studied. We can compare the sequences of the mRNA produced to 
that of the known structure of the two predominant IGF-1 mRNA transcripts. The 
postulated long distance interactions between the Stat5b binding sites and the promoters 
can be studied using methods known as chromosome conformation capture (3C) or 
circular chromosome conformation capture (4C). Both methods involve stimulating the 
cells with GH for various amounts of time and then essentially freezing the DNA in its 
conformation during transcription. The DNA can then be digested, ligated, and tested for 
interaction. The 4C method is more of a screening tool in which any DNA interacting 
with the promoter will be identified. The 3C method is more of a confirmation tool that is 
positive only if there are interactions between the known regions of DNA, in this case the 
promoter and Stat5b enhancer regions.  
Future Implications. This model system is vital to answering questions about the 
mechanism by which Stat5b mediated GH regulation of IGF-1 transcription functions. 
Once this system can be established further modification of this system may help to 
answer different questions. A long term goal of this project would be isolate the key 
Stat5b site(s) needed to promote transcription. These sites could be isolated using a 
method known as chromosome immunoprecipation (ChIP) which shows protein-DNA 
interactions. After confirming the sites which Stat5b binds, the all the sites can be either 
removed completely, all can be removed except one, or only one site can be removed at a 
time. After the levels of IGF-1 transcription have been established by the native system, 
this data can be used to compare to other systems in which the Stat5b binding sites are 
removed or transclocated. There could be no change in the transcription levels indicating 
the removed site may not be the key site or the amount of transcription may be reduced 
indicating it may be a part of multiple sites required for transcription. It could also 
completely stop the production of IGF-1 protein meaning that it may be a critical site. If 
the important site(s) can be narrowed down, the structure of both the protein and the 
mRNA can be compared to the native model system. It is possible the removal of the 
sites may have an effect on the structure of the IGF-1 proteins and mRNA. The long 
distance interactions between the site and the promoter can also examined to see if the 
interaction still occurs, or if the site being removed or transclocated has an effect on how 
the DNA conforms upon GH stimulation. As has been described, if this system can be 
established, many questions about this mechanism can be studied.  
Conclusion 
The GH regulation IGF-1 transcription is a process integral to growth, tissue repair, and 
metabolism. The exact mechanism by which Stat5b mediates this process is still not clear 
though it has been established is critical to initiate transcription by previous research. 
Since there is no model system in place to study this mechanism, one will be created 
which will provide the material necessary to closely examine Stat5b. A BAC containing 
the IGF-1 gene will be modified with an antibiotic selection marker, linearized, and 
inserted into a cell line. This cell line will select for the integrated gene using antibiotic 
selection and a stable cell line will be created. If this model system can be established, 
questions about the mechanism of Stat5b interaction with the DNA can be examined to 
help elucidate the pathway. Longer term goals include removing the putative Stat5b 
binding sites from the BAC to help isolate the most important sites. If successful, this 
project can help to answer larger questions about the role of Stat5b in GH/IGF-1 growth 
axis in humans.  
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Appendices 
 
Appendix A. Polymerase Chain Reaction (PCR). The purpose of PCR is to create an abundance 
of a small stretch (500 bp‐4kbp for genomic DNA1) of DNA. In this case, it was used in two ways: 
To make template for downstream applications and to confirm the presence of insert. To make 
template, primers must be designed that surround the desired region on DNA to be replicated. 
For our purposes, there was also restriction sites added so cloning in the fragment was possible.  
CH0113M6 BAC was used as a template for the arms to be cloned into the PL452 vector. PCR 
was also used as a confirmation tool as shown in Figure 5B. The only possible way for a signal to 
be produced is if the template is present exactly as shown. If there is no template then there 
will be no signal. 
 
Appendix B. Electroporation. The technique of electroporation is used in homologous 
recombination and for integrating large fragments of DNA. In this case, it was used for 
recombining the Neo cassette into recombinant E. coli and for transfecting the Cos7 cells with 
the linearized Neo containing M6 BAC.  
   
                                                             
1 Davies, P.A.; Gray, 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